help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neulen, J.
Right arrow Articles by Breckwoldt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neulen, J.
Right arrow Articles by Breckwoldt, M.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 1967-1971, Copyright © 1995 by Endocrine Society

ARTICLES

Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome

J Neulen, Z Yan, S Raczek, K Weindel, C Keck, HA Weich, D Marme and M Breckwoldt
Department of Obstetrics and Gynecology, University of Freiburg, Germany.

Ovarian hyperstimulation syndrome (OHSS) is a severe complication arising from controlled ovarian stimulation treatment. This iatrogenic condition is potentially lethal and occurs in 0.3-5% of stimulated ovarian cycles. hCG exacerbates OHSS. The pathophysiology of OHSS is still unknown; therefore, treatment regimens are aimed at ameliorating symptoms. Prominent features of OHSS are an elevated risk of thromboembolism due to enhanced production of von Willebrand factor by endothelial cells and ascites, or pulmonary edema due to increased vascular permeability followed by third space fluid accumulation. Both of these sequelae can be evoked by vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF). High concentrations of VEGF/VPF have been demonstrated in ascitic fluid from patients with OHSS, but the source of VEGF/VPF in these patients remained unidentified. Here we report that the messenger ribonucleic acid expression of VEGF/VPF in human luteinized granulosa cells (GCs) is dose and time dependently enhanced by hCG in vitro. Furthermore, VEGF/VPF proteins are produced by GCs. Our results suggest that the effects of hCG on the development and course of OHSS may be mediated by the production of VEGF/VPF by GCs.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
W. C. Duncan, S. van den Driesche, and H. M. Fraser
Inhibition of Vascular Endothelial Growth Factor in the Primate Ovary Up-Regulates Hypoxia-Inducible Factor-1{alpha} in the Follicle and Corpus Luteum
Endocrinology, July 1, 2008; 149(7): 3313 - 3320.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. R. Soares, R. Gomez, C. Simon, J. A. Garcia-Velasco, and A. Pellicer
Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome
Hum. Reprod. Update, April 2, 2008; (2008) dmn008v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S.-U. Chen, C.-H. Chou, H. Lee, C.-H. Ho, C.-W. Lin, and Y.-S. Yang
Lysophosphatidic Acid Up-Regulates Expression of Interleukin-8 and -6 in Granulosa-Lutein Cells through Its Receptors and Nuclear Factor-{kappa}B Dependent Pathways: Implications for Angiogenesis of Corpus Luteum and Ovarian Hyperstimulation Syndrome
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 935 - 943.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Alvarez, I. Alonso-Muriel, G. Garcia, J. Crespo, J. Bellver, C. Simon, and A. Pellicer
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study
Hum. Reprod., December 1, 2007; 22(12): 3210 - 3214.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Handschuh, J. Guibourdenche, V. Tsatsaris, M. Guesnon, I. Laurendeau, D. Evain-Brion, and T. Fournier
Human Chorionic Gonadotropin Produced by the Invasive Trophoblast But Not the Villous Trophoblast Promotes Cell Invasion and Is Down-Regulated by Peroxisome Proliferator-Activated Receptor-{gamma}
Endocrinology, October 1, 2007; 148(10): 5011 - 5019.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Alvarez, L. Marti-Bonmati, E. Novella-Maestre, R. Sanz, R. Gomez, M. Fernandez-Sanchez, C. Simon, and A. Pellicer
Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2931 - 2937.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. B. Stanek, S. M. Borman, T. A. Molskness, J. M. Larson, R. L. Stouffer, and P. E. Patton
Insulin and Insulin-Like Growth Factor Stimulation of Vascular Endothelial Growth Factor Production by Luteinized Granulosa Cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and Non-PCOS Women
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2726 - 2733.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Kosaka, H. Fujiwara, S. Yoshioka, and S. Fujii
Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome
Hum. Reprod., June 1, 2007; 22(6): 1647 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
D. L. Russell and R. L. Robker
Molecular mechanisms of ovulation: co-ordination through the cumulus complex
Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. H. M. Lozano, N. Frydman, J. M. Levaillant, S. Fay, R. Frydman, and R. Fanchin
The 3D vascular status of the follicle after HCG administration is qualitatively rather than quantitatively associated with its reproductive competence
Hum. Reprod., April 1, 2007; 22(4): 1095 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
N. F. VLAHOS and O. GREGORIOU
Prevention and Management of Ovarian Hyperstimulation Syndrome
Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 247 - 264.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Gomez, M. Gonzalez-Izquierdo, R. C. Zimmermann, E. Novella-Maestre, I. Alonso-Muriel, J. Sanchez-Criado, J. Remohi, C. Simon, and A. Pellicer
Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation Model
Endocrinology, November 1, 2006; 147(11): 5400 - 5411.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Ledoux, D. B. Campos, F. L. Lopes, M. Dobias-Goff, M.-F. Palin, and B. D. Murphy
Adiponectin Induces Periovulatory Changes in Ovarian Follicular Cells
Endocrinology, November 1, 2006; 147(11): 5178 - 5186.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Tesarik, A. Hazout, R. Mendoza-Tesarik, N. Mendoza, and C. Mendoza
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles
Hum. Reprod., October 1, 2006; 21(10): 2572 - 2579.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Tropea, F. Miceli, F. Minici, F. Tiberi, M. Orlando, M. F. Gangale, F. Romani, S. Catino, S. Mancuso, P. Navarra, et al.
Regulation of Vascular Endothelial Growth Factor Synthesis and Release by Human Luteal Cells in Vitro
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2303 - 2309.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Tang, J. Glanville, N. Orsi, J. H. Barth, and A. H. Balen
The use of metformin for women with PCOS undergoing IVF treatment
Hum. Reprod., June 1, 2006; 21(6): 1416 - 1425.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Babayof, E. J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, M. Gal, B. Brooks, T. Mimoni, and T. Eldar-Geva
Serum inhibin A, VEGF and TNF{alpha} levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial
Hum. Reprod., May 1, 2006; 21(5): 1260 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Tesarik, A. Hazout, and C. Mendoza
Reply: Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation
Hum. Reprod., January 1, 2006; 21(1): 324 - 325.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
E. H. Y. Ng, C. C. W. Chan, W. S. B. Yeung, and P. C. Ho
Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome
Hum. Reprod., July 1, 2005; 20(7): 1881 - 1886.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
R Gruemmer, L Klein-Hitpass, and J Neulen
Regulation of gene expression in endothelial cells: the role of human follicular fluid
J. Mol. Endocrinol., February 1, 2005; 34(1): 37 - 46.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. M. Fraser, J. Bell, H. Wilson, P. D. Taylor, K. Morgan, R. A. Anderson, and W. C. Duncan
Localization and Quantification of Cyclic Changes in the Expression of Endocrine Gland Vascular Endothelial Growth Factor in the Human Corpus Luteum
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 427 - 434.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
T Sakurai, K Tamura, and H Kogo
Vascular endothelial growth factor increases messenger RNAs encoding cyclooxygenase-II and membrane-associated prostaglandin E synthase in rat luteal cells
J. Endocrinol., December 1, 2004; 183(3): 527 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. H. Y. Ng, C. C. W. Chan, W. S. B. Yeung, and P. C. Ho
Effect of age on ovarian stromal flow measured by three-dimensional ultrasound with power Doppler in Chinese women with proven fertility
Hum. Reprod., September 1, 2004; 19(9): 2132 - 2137.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
R Gomez, I Lima, C Simon, and A Pellicer
Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats
Reproduction, April 1, 2004; 127(4): 483 - 489.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T.A. Molskness, R.L. Stouffer, K.A. Burry, M.J. Gorrill, D.M. Lee, and P.E. Patton
Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women
Hum. Reprod., April 1, 2004; 19(4): 822 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A.J. Tozer, R.K. Iles, E. Iammarrone, C.M.Y. Gillott, T. Al-Shawaf, and J.G. Grudzinskas
The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome
Hum. Reprod., March 1, 2004; 19(3): 522 - 528.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. H. Rudolfsson, P. Wikstrom, A. Jonsson, O. Collin, and A. Bergh
Hormonal Regulation and Functional Role of Vascular Endothelial Growth Factor A in the Rat Testis
Biol Reprod, February 1, 2004; 70(2): 340 - 347.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. Gomez, C. Simon, J. Remohi, and A. Pellicer
Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability
Biol Reprod, June 1, 2003; 68(6): 2164 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. J. K. Anand, H.-J. Paust, K. Altenpohl, and A. K. Mukhopadhyay
Regulation of Vascular Endothelial Growth Factor Production by Leydig Cells In Vitro: The Role of Protein Kinase A and Mitogen-Activated Protein Kinase Cascade
Biol Reprod, May 1, 2003; 68(5): 1663 - 1673.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
A. C. Villablanca, K. A. Lewis, D. Tham, and J. C. Rutledge
Differential regulation of gene expression by ovariectomy in mouse aorta
Physiol Genomics, February 6, 2003; 12(3): 175 - 185.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Zygmunt, F. Herr, S. Keller-Schoenwetter, K. Kunzi-Rapp, K. Munstedt, C. V. Rao, U. Lang, and K. T. Preissner
Characterization of Human Chorionic Gonadotropin as a Novel Angiogenic Factor
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5290 - 5296.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Gomez, C. Simon, J. Remohi, and A. Pellicer
Vascular Endothelial Growth Factor Receptor-2 Activation Induces Vascular Permeability in Hyperstimulated Rats, and this Effect Is Prevented by Receptor Blockade
Endocrinology, November 1, 2002; 143(11): 4339 - 4348.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T.-H. Wang, S.-G. Horng, C.-L. Chang, H.-M. Wu, Y.-J. Tsai, H.-S. Wang, and Y.-K. Soong
Human Chorionic Gonadotropin-Induced Ovarian Hyperstimulation Syndrome Is Associated with Up-Regulation of Vascular Endothelial Growth Factor
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3300 - 3308.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B. McElhinney, J. Ardill, C. Caldwell, F. Lloyd, and N. McClure
Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others?
Hum. Reprod., June 1, 2002; 17(6): 1548 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Albert, N. Garrido, A. Mercader, C.V. Rao, J. Remohi, C. Simon, and A. Pellicer
The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome
Mol. Hum. Reprod., May 1, 2002; 8(5): 409 - 418.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. C. Villablanca, K. A. Lewis, and J. C. Rutledge
Time- and dose-dependent differential upregulation of three genes by 17beta -estradiol in endothelial cells
J Appl Physiol, March 1, 2002; 92(3): 1064 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
M. Mattioli, B. Barboni, M. Turriani, G. Galeati, A. Zannoni, G. Castellani, P. Berardinelli, and P. A. Scapolo
Follicle Activation Involves Vascular Endothelial Growth Factor Production and Increased Blood Vessel Extension
Biol Reprod, October 1, 2001; 65(4): 1014 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J.L. Benifla, A.F. Bringuier, C. Sifer, R. Porcher, P. Madelenat, and G. Feldmann
Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF
Hum. Reprod., July 1, 2001; 16(7): 1376 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Neulen, D. Wenzel, C. Hornig, E. Wunsch, U. Weissenborn, K. Grunwald, R. Buttner, and H. Weich
Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols
Hum. Reprod., April 1, 2001; 16(4): 621 - 626.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Sugino, S. Kashida, S. Takiguchi, A. Karube, and H. Kato
Expression of Vascular Endothelial Growth Factor and Its Receptors in the Human Corpus Luteum during the Menstrual Cycle and in Early Pregnancy
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3919 - 3924.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
B. Barboni, M. Turriani, G. Galeati, M. Spinaci, M. L. Bacci, M. Forni, and M. Mattioli
Vascular Endothelial Growth Factor Production in Growing Pig Antral Follicles
Biol Reprod, September 1, 2000; 63(3): 858 - 864.
[Abstract] [Full Text]

Home page
 Reproductive SciencesHome page
E. Levitas, D. Chamoun, L. C. Udoff, M. Ando, C. E. Resnick, and E. Y. Adashi
Periovulatory and Interleukin-1{beta}-Dependent Up-Regulation of Intraovarian Vascular Endothelial Growth Factor (VEGF) in the Rat: Potential Role for VEGF in the Promotion of Periovulatory Angiogenesis and Vascular Permeability
Reproductive Sciences, January 1, 2000; 7(1): 51 - 60.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
M. Ludwig, W. Jelkmann, O. Bauer, and K. Diedrich
Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
Hum. Reprod., October 1, 1999; 14(10): 2437 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. Doldi, A. Destefani, A. Gessi, D. Grossi, and A. Ferrari
Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome
Hum. Reprod., May 1, 1999; 14(5): 1157 - 1159.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
R. Orvieto and Z. Ben-Rafael
Ovarian Hyperstimulation Syndrome: A New Insight Into an Old Enigma
Reproductive Sciences, May 1, 1998; 5(3): 110 - 113.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
M. Laitinen, A. RistimAki, M. Honkasalo, K. Narko, K. Paavonen, and O. Ritvos
Differential Hormonal Regulation of Vascular Endothelial Growth Factors VEGF, VEGF-B, and VEGF-C Messenger Ribonucleic Acid Levels in Cultured Human Granulosa-Luteal Cells
Endocrinology, November 1, 1997; 138(11): 4748 - 4756.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
K. A. Roberts, M. M. Woo, and J. C. Rutledge
Nitric Oxide Mediates LDL Uptake in the Artery Wall in Response to High Concentrations of 17ß-Estradiol
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2123 - 2131.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. K. Christenson and R. L. Stouffer
Follicle-Stimulating Hormone and Luteinizing Hormone/Chorionic Gonadotropin Stimulation of Vascular Endothelial Growth Factor Production by Macaque Granulosa Cells from Pre- and Periovulatory Follicles
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2135 - 2142.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Sato, M. Miyakawa, N. Onoda, H. Demura, T. Yamashita, M. Miura, T. Kasajima, K. Yamazaki, and T. Obara
Increased Concentration of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Cyst Fluid of Enlarging and Recurrent Thyroid Nodules
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1968 - 1973.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society